Clinical Trial Update: Intracoronary Bolus Only Compared With Intravenous Bolus and 12-hours Infusion of Abciximab in Non-ST Elevation Myocardial Infarction. [Phase 4]

View source ↗

Summary

Phase 4 trial comparing intracoronary bolus, intravenous bolus, and 12-hour infusion of Abciximab in non-ST elevation myocardial infarction; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Abciximab (abciximab)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Myocardial Infarction, Angioplasty | Phase 4 | Status: TERMINATED